Revenio Group Oyj (REG1V.HE) Stock Analysis & Winston Score

Revenio Group is a Finnish medical device company best known for its iCare brand of tonometers — instruments that measure eye pressure to screen for glaucoma. Its devices are used by ophthalmologists, optometrists, and general practitioners, as well as by patients at home. iCare tonometers are distinctive because they use a small probe that briefly touches the eye, requiring no anesthesia or air puff. The company earns revenue by selling its devices and single-use probes, creating a recurring consumables stream alongside hardware sales. Revenio operates globally, with strong positions in Europe and the United States, and has a market cap around $0.4 billion. Its competitive moat rests on patented rebound tonometry technology and a large installed base that drives ongoing probe purchases. Key growth depends on expanding home-monitoring adoption and penetrating primary care settings, though the company faces risks from its heavy reliance on a single product category.